Research progress of the levonorgestrel-releasing intrauterine system for the treatment of common gynecological diseases

Qin Huang,Yingqiong Yang
DOI: https://doi.org/10.3760/CMA.J.CN101441-20190418-00160
2020-03-25
Abstract:In recent years, the incidence of uterine fibroids, endometriosis, adenomyosis, endometrial hyperplasia and other common gynecological diseases is increasing, and the patients are getting younger, which seriously affects patients' quality of life. Medical research shows that these diseases are associated with abnormal regulation of estrogen, progesterone and other hormones. Many domestic and foreign studies found that levonorgestrel-releasing intrauterine system (LNG-IUS) could improve the menstrual bleeding and other symptoms of uterine fibroids. The clinical efficacy of endometriosis is similar to that of gonadotropin-releasing hormone agonist (GnRH-a) or progesterone, and can effectively improve the dysmenorrhea symptoms of adenomyosis. In addition, in the treatment of endometrial hyperplasia, LNG-IUS and progesterone treatment is equal to or better than the latter. Therefore, in recent years, LNG-IUS has been widely used in clinical practice and has achieved certain curative effect. This paper reviews the literatures about LNG-IUS in the treatment of common gynecological diseases at home and abroad. Key words: Levonorgestrel-releasing intrauterine system; Gynecological diseases; Curative effect
Medicine
What problem does this paper attempt to address?